Cargando…
Hypokalemia-Induced Arrhythmias and Heart Failure: New Insights and Implications for Therapy
Routine use of diuretics and neurohumoral activation make hypokalemia (serum K(+) < 3. 5 mM) a prevalent electrolyte disorder among heart failure patients, contributing to the increased risk of ventricular arrhythmias and sudden cardiac death in heart failure. Recent experimental studies have sug...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234658/ https://www.ncbi.nlm.nih.gov/pubmed/30464746 http://dx.doi.org/10.3389/fphys.2018.01500 |
Sumario: | Routine use of diuretics and neurohumoral activation make hypokalemia (serum K(+) < 3. 5 mM) a prevalent electrolyte disorder among heart failure patients, contributing to the increased risk of ventricular arrhythmias and sudden cardiac death in heart failure. Recent experimental studies have suggested that hypokalemia-induced arrhythmias are initiated by the reduced activity of the Na(+)/K(+)-ATPase (NKA), subsequently leading to Ca(2+) overload, Ca(2+)/Calmodulin-dependent kinase II (CaMKII) activation, and development of afterdepolarizations. In this article, we review the current mechanistic evidence of hypokalemia-induced triggered arrhythmias and discuss how molecular changes in heart failure might lower the threshold for these arrhythmias. Finally, we discuss how recent insights into hypokalemia-induced arrhythmias could have potential implications for future antiarrhythmic treatment strategies. |
---|